Medicine and Dentistry
Patient
100%
Endometrial Cancer
58%
Neoplasm
34%
Therapeutic Procedure
33%
Woman
32%
Diagnosis
30%
Ovarian Cancer
25%
Obesity
21%
Lesion
20%
Combination Therapy
17%
Adipose Tissue
17%
Cells
16%
Age
16%
Estrogen Receptor Beta
14%
Hysterectomy
14%
Diseases
13%
Clomifene Citrate
13%
Receptor
13%
Adenocarcinoma
13%
Malignant Neoplasm
12%
Laparoscopy
11%
Survival
11%
Race
11%
Predictor
10%
Assessment
10%
Stromal Cell
10%
Analysis
9%
Coccidioidomycosis
9%
Leuprorelin
9%
Compartment Syndrome
9%
Indigo Carmine
9%
Uterine Cervix Biopsy
9%
Adenocarcinoma in Situ
9%
Provocation Test
9%
Hysteroscopy
9%
Culture
9%
Plasminogen Activator Inhibitor-1
9%
Hispanic
9%
Tumor Necrosis Factor Receptor
9%
Histology
8%
Cell Communication
8%
Evaluation Study
8%
Human Leukocyte Antigen
8%
Beta Adrenergic Receptor Stimulating Agent
8%
Squamous Metaplasia
8%
Surgery
8%
Follow up
8%
Cytolysis
8%
Cancer Stem Cell
8%
Assay
8%
Pharmacology, Toxicology and Pharmaceutical Science
Endometrium Cancer
35%
Neoplasm
28%
Ovary Cancer
25%
Estrogen Receptor Beta
14%
Receptor
13%
Obesity
11%
Malignant Neoplasm
10%
Adenocarcinoma
10%
Compartment Syndrome
9%
Adenocarcinoma in Situ
9%
Leuprorelin
9%
Indigo Carmine
9%
Coccidioidomycosis
9%
Tumor Necrosis Factor Receptor
9%
Beta Adrenergic Receptor Stimulating Agent
8%
Squamous Cell Metaplasia
8%
Survival
7%
Postpartum Hemorrhage
7%
Leukemia Inhibitory Factor Receptor
7%
Tumor Necrosis Factor
7%
Tumor Growth
6%
Female Genital Tuberculosis
6%
Prevalence
6%
Mammalian Target of Rapamycin Inhibitor
5%
Ovary Tumor
5%
Incidence
5%
Monoclonal Antibody
5%
Biochemistry, Genetics and Molecular Biology
Estrogen Receptor Beta
14%
Nested Gene
12%
Age
12%
Adhesion
11%
Stromal Cell
10%
Tumor Necrosis Factor
9%
Staining Technique
9%
Cell Communication
8%
Human Leukocyte Antigen
8%
Agonist
8%
Mammalian Target of Rapamycin
8%
Growth
7%
Leukemia Inhibitory Factor Receptor
7%
Adipocyte
7%
Development
6%
Cancer Stem Cell
6%
Ovulation
6%
Proband
6%
Luteal Phase
6%
Human Immunodeficiency Virus
6%
Cancer Cell
6%
Gonadotropin
5%
Electric Potential
5%
Defense Mechanism
5%
GJA1
5%
Incidence
5%
